The main objective of the Lipid and Lipoprotein Laboratory, headed by Petar Alaupovic, Ph.D., is to study the chemical, metabolic and pathiophysiologic properties of human plasma lipoproteins. Our studies are based on the concept that protein components (apolipoproteins) play the essential role in the structural integrity and functional specificity of plasma lipoproteins.

   [MORE]   [LESS]

2012

Bagdade JD, Knight-Gibson C, Simpson N, Gerkin R, Alaupovic P, Reardon C. CETP-mediated cholesteryl ester enrichment of apoB subclasses in type 1 diabetes. Eur J Clin Invest 2012. [Abstract] EPub

Basu A, Alaupovic P, Wu M, Jenkins AJ, Yu Y, Nankervis AJ, Hanssen KF, Scholz H, Henriksen T, Lorentzen B, Clausen T, Garg SK, Menard MK, Hammad SM, Scardo JA, Stanley JR, Dashti A, Aston CE, Lyons TJ. Plasma Lipoproteins and Preeclampsia in Women with Type 1 Diabetes: A Prospective Study. J Clin Endocrinol Metab 2012. [Abstract] EPub

* Knowlton N, Wages J, Centola M, Giles J, Bathon J, Quiroga C, Alaupovic P. Apolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012. [Abstract] EPub

Roussell MA, Hill AM, Gaugler TL, West SG, Vanden Heuvel JP, Alaupovic P, Gillies PJ, Kris-Etherton PM. Beef in an Optimal Lean Diet study: effects on lipids, lipoproteins, and apolipoproteins. Am J Clin Nutr 95:9-16, 2012. [Abstract]

* Indications publications by more than one department

Lipid and Lipoprotein Laboratory
Oklahoma Medical Research Foundation
825 NE 13th Street, MS  42
Oklahoma City, OK 73104

Phone: (405) 271-7702
Fax: (405) 271-8575
Email: nancy-simpson@omrf.org